Opportunities for expanding access to product information for - PowerPoint PPT Presentation

Opportunities for expanding access to product information for medicines: Stakeholders’ needs and challenges’ from a perspective of a healthcare professional Darragh J O’Loughlin Secretary General, IPU Past President, PGEU 28/11/2018 www.pgeu.eu

Pharmacist view on product information  1 . Paper package leaflets are widely used  4 . Opportunities exist for better linkage to risk- by patients/public as a complement to minimisation information information received from HCP 2 . Vital that patients can access objective 5 . SmPC information (electronically available through and neutral information on pharmaceuticals NCA/EMA websites) is often directly integrated in at home to ensure confidence and patient software programmes of HCPs to improve user- empowerment friendliness and accessibility for HCPs 6 . Updated PI: Opportunities for electronic alerting 3. Readability still is a common complaint to HCP so that updated information can be from patients/consumers due to inadequate addressed in the appropriate context to the format/lay-out & language patient/consumer At the hearth of European communities 2

Key elements of product information Accessibility & convenience Objectivity & independence  Appropriate format & design to improve  Objective / non-promotional nature readability and engagement  Patients / consumers electronically directed to  Focus on adapted lay-language & multi-lingual independent source of information choice Universality Complementarity  Meeting special patient needs (e.g. migrants,  Paper leaflet is still a vital source of information low literacy, disabled persons) through e.g. at home for many patients & consumers audible formats and / or using symbols on  No universal access of population to digital tools medicines use  Additional risk-minimisation communication  Taking into account digital and non-digital opportunities literate patients / consumers At the hearth of European communities

Examples : Electronic risk-minimisation Electronic alerting to HCP communication Integrating targeted communication tools At the hearth of European communities 4

Example: Adapted electronic format At the hearth of European communities 5

Opportunities for expanding access to product information for medicines Electronic product information can increase access and engagement 1 through providing a more user-friendly and readable format Unique opportunity to meet special patients’ needs , including a 2 multi-lingual choice option 3 Linkage with risk-minimisation communication to patients & HCPs EU-wide standards can ensure harmonised access for patients & HCPs 4 across EU Electronic alerting to HCPs so that all updated PI can be addressed in the 5 appropriate context to patients At the hearth of European communities 6

THANK YOU! Pharmaceutical Group of the European Union (PGEU) Rue du Luxembourg 19, 1000 Brussels, Belgium +32 (0)2 238 08 18 pharmacy@pgeu.eu www.pgeu.eu